Kristien Verhoeven is a seasoned life sciences executive with deep expertise in histopathology, genomics, and biomedical innovation. She is CellCarta’s Senior Vice President of the Histopathology, Genomics, and Logistics Business Units, where she leads strategic direction and operational oversight for these global business segments.

Kristien previously served as Head of Operations at HistoGeneX, where she played a key role in expanding and optimizing laboratory services. Before that, she was the Global Head of Implant Biology at Cochlear, where she led groundbreaking work in the development and clinical trials of a cochlear implant integrated with drug delivery — a first of its kind in the field.

Kristien holds a PhD in Medical Sciences, an MBA from the University of Antwerp, and completed executive education in Global Management at INSEAD.